Evidence map›Paper›PMID 38187718›Full record

ArticlebioRxiv : the preprint server for biology2023

Kappa Opioid Receptors in Mesolimbic Terminals Mediate Escalation of Cocaine Consumption.

L Gordon-Fennell, R D Farero, L M Burgeno, N L Murray, A D Abraham, M E Soden, G D Stuber, C Chavkin, L S Zweifel, P E M Phillips

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

L Gordon-FennellGraduate Program in Neuroscience, University of Washington, Seattle, WA 98195.
R D FareroGraduate Program in Neuroscience, University of Washington, Seattle, WA 98195.
L M BurgenoCenter for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.
N L MurrayCenter for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.
A D AbrahamCenter for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.
M E SodenCenter for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, WA 98195.
G D StuberGraduate Program in Neuroscience, University of Washington, Seattle, WA 98195.
C ChavkinGraduate Program in Neuroscience, University of Washington, Seattle, WA 98195.
L S ZweifelGraduate Program in Neuroscience, University of Washington, Seattle, WA 98195.
P E M PhillipsGraduate Program in Neuroscience, University of Washington, Seattle, WA 98195.ORCID 0000-0002-8749-7026
University of Washington · US

Funding

University of Washington Center of Excellence in Opioid Addiction ResearchP30DA048736 · NIDA · UNIVERSITY OF WASHINGTON · PI Charles Chavkin · 2019 to 2026
$13.0M
TRAINING IN THE MOLECULAR PHARMACOLOGY OF ABUSED DRUGST32DA007278 · NIDA · UNIVERSITY OF WASHINGTON · PI Susan Marie Ferguson, Paul E. M. Phillips · 1993 to 2026
$9.8M
Neural mechanisms regulating cocaine consumptionR37DA051686 · NIDA · UNIVERSITY OF WASHINGTON · PI PHILLIPS, PAUL E. M. · 2020 to 2024
$2.5M
Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seekingR01DA039687 · NIDA · UNIVERSITY OF WASHINGTON · PI PHILLIPS, PAUL E. M. · 2015 to 2019
$1.7M
Neuromodulatory mechanisms mediating escalation of drug consumptionF31DA048562 · NIDA · UNIVERSITY OF WASHINGTON · PI FARERO, RYAN D · 2020 to 2021
$63k
NIDA NIH HHS F31 DA048562NIDA NIH HHS P30 DA048736NIDA NIH HHS R01 DA039687NIDA NIH HHS R37 DA051686NIDA NIH HHS T32 DA007278
6 · The paper itself

Abstract

Increases in drug consumption over time, also known as escalation, is a key behavioral component of substance use disorder (SUD) that is related to potential harm to users, such as overdose. Studying escalation also allows researchers to investigate the transition from casual drug use to more SUD-like drug use. Understanding the neurobiological systems that drive this transition will inform therapeutic treatments in the aim to prevent increases in drug use and the development of SUD. The kappa opioid receptor (KOR) system is typically known for its role in negative affect, which is commonly found in SUD as well. Furthermore, the KOR system has also been implicated in drug use and importantly, modulating the negative effects of drug use. However, the specific neuronal subpopulation expressing KOR involved has not been identified. Here, we first demonstrated that pharmacologically inhibiting KOR in the nucleus accumbens core (NAcC), as a whole, blocks cocaine escalation under long-access self-administration conditions. We then demonstrated that KOR expressed on ventral tegmental area (VTA) neurons but not NAcC neurons is sufficient for blocking cocaine escalation by utilizing a novel virally-mediated CRISPR-SaCas9 knock-out of the

Identifiers

PMID38187718
PMCPMC10769440
OpenAlexW4390140126

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.